Genomics Services Market size was valued at USD 16.4 billion in 2022 and is estimated to reach USD 46.4 billion in 2030, and grow at a compound annual growth rate approx. CAGR of 12.8% over the forecast period of 2023-2030.
The Genomics Services Market Report provides a comprehensive analysis of the global Genomics Services market, highlighting key trends, growth drivers, challenges, and opportunities. The report aims to assist industry stakeholders in making informed decisions and formulating effective strategies.
The genomics services market is a rapidly growing sector that encompasses a wide range of services related to the study and analysis of an individual’s genetic material. With advancements in technology and decreasing costs of genomic sequencing, the demand for genomics services has witnessed a significant surge in recent years.
Get Free PDF Sample Report: https://www.snsinsider.com/sample-request/2873
One of the key drivers behind the growth of this market is the increasing adoption of personalized medicine. Genomic information plays a crucial role in tailoring medical treatments to an individual’s unique genetic makeup, allowing for more precise and effective therapies. As a result, healthcare providers are increasingly relying on genomics services to guide their treatment decisions, leading to a higher demand for genetic testing, sequencing, and analysis.
Moreover, the expanding applications of genomics in various fields such as oncology, rare diseases, reproductive health, and pharmacogenomics have further fueled the growth of this market. Researchers are continuously discovering new genetic markers associated with diseases or drug responses, creating opportunities for genomics service providers to offer specialized tests and analysis.
KEY MARKET SEGMENTS
By Application & Deliverables
- Functional Genomics
- Pathway Analysis
- Biomarker Discovery
- Consumables & Reagents
- NGS-based Services
- Core Genomics Services
- Biomarker Translation Services
- Computational Services
By End users
- Clinical Research
- Academic & Government Institutes
- Hospitals & Clinic
- Pharmaceutical & Bio Technology Companies
- Other End Users
Major Players Listed in the Report are as Follows:
- Hoffmann-La Roche Ltd, Agilent Technologies, Thermo Fisher Scientific, Inc, Bio-Rad Laboratories, Inc, 23andMe, Inc., Illumina, Inc, Myriad Genetics, Inc., Foundation Medicine, Inc., Danaher, Pacific Biosciences, Oxford Nanopore Technologies, BGI and others.
SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.
We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.
Akash Anand – Head of Business Development & Strategy,
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)